Jci_page_head_homepage_01 Jci_page_head_homepage_02
Jennifer L. Gommerman, Fabienne Mackay, Elina Donskoy, Werner Meier, Pauline Martin, Jeffrey L. Browning
Published in Volume 110, Issue 9
J Clin Invest. 2002; 110(9):1359–1369 doi:10.1172/JCI15975
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

B cell and T cell areas are mostly unaltered by LTβR-Ig treatment, but CD21 staining is diminished. Representative spleens from untreated (a, d, g), treated (8 mg/kg LTβR-Ig) (b, e, h), and recovery animals (8 mg/kg treatment followed by 3-month recovery) (c, f, i) were stained with anti-CD20 Ab’s (blue). Sections were costained with anti-CD3 Ab’s (brown) (ac), or the FDC-specific clone CNA.42 (brown) (df), or the CD21-specific R42/3 clone (dark brown) (gi). Spleens were photographed at ×100. T, T cell zone; T/B interface, T cell/B cell interface.